<?xml version="1.0" encoding="UTF-8"?>
<results title="country">
 <result pre="between CVL218 and arbidol, a broad-spectrum antiviral drug commercialized in" exact="China" post="since 2016, had been recommended to treat the SARS-CoV-2-infected"/>
 <result pre="trial in 2017 by National Medical Products Administration (NMPA) in" exact="China" post="for cancer treatment. The preliminary data from the Phase"/>
 <result pre="supported in part by the National Natural Science Foundation of" exact="China" post="(61872216, 81630103, 31900862), Jiangsu Provincial Emergency Project on Prevention"/>
</results>
